Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Scientists in the Kennedy Institute, NDORMS show anti-TNF inhibits the cells responsible for Dupuytren’s disease.

Dupuytren’s disease hand examination.
Load More

PROFESSOR Jagdeep Nanchahal talks about the Trial

Read the paper

The findings are published on line in the journal EBioMedicine, published by The Lancet.

FIND OUT ABOUT THE TRIAL

RIDD

Funded by

Wellcome Trust logo

Department of Health and Social Care logo

 

Funding for the drug was provided by 180 Therapeutics.